Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial | Oncology | JAMA Oncology | JAMA Network https://t.co/j2Wgi8RvQ8
RT @nachoduranm: Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer https://t.co/qcRJmATsva
ORIOLE study from Dr. Phuoc Tran and team out in JAMA Onc showing benefit to treatment of PSMA-PET defined oligometastatic cancer with SBRT! What a great study and phenomenal work! https://t.co/ygkni1Jveh Editorial accompanies it by Greco/Fuks.. (1/2)
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. https://t.co/Gf6fVwbqq6
Nice test of principle primarily in nodal recurrence, but so much more clinical trial work needed to define role and treatment algorithms in context of multiple other treatment strategies. Let’s use this as a “battle cry” to press forward.
Congratulations (again) to my friend and colleague Dr. Phuoc Tran for his vision and persistence. Thank you @PCFnews @PCF_Science for support and commitment. Grateful I was able to participate. @KimmelCancerCtr @JeffersonUniv. https://t.co/01aiRGCWuQ h
Stereotactic ablative radiotherapy reduces disease progressions and short-term need for ADT in low-volume, hormone-sensitive metastatic #prostatecancer Mets detected with conventional imaging, effect greater If all PSMA-PET positive lesions are treated h
RT @nachoduranm: Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer https://t.co/qcRJmATsva
Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer https://t.co/qcRJmATsva
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
Stereotactic #radiotherapy slows down the spread of the tumour for #prostatecancer? Nice! https://t.co/KXwAGC2exD
RT @ChristenElledge: So proud of my colleagues at Hopkins! Check out the results of the ORIOLE trail, everyone! #radonc #JohnsHopkins Obs…
Radiation therapy can stop progression of metastatic prostate cancer for up to 6 months, if metastatic sites are identified. (Read more: https://t.co/iiucegWlkj) These Canadian men with prostate cancer share their experience with radiation therapy: https:
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. 𝙅𝘼𝙈𝘼 𝙊𝙣𝙘𝙤𝙡. #ProstateCancer https://t.co/IsiN7RxfSI
In a phase II trial in 54 men with recurrent CSPC and 1-3 metastases, progression of disease at 6 months occurred in 7 of 36 (19%) treated with stereotactic ablative radiotherapy of oligometastatic disease and in 11 of 18 (61%) undergoing observation: http
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
Finally ORIOLE results are here 👏🏻👏🏻👏🏻😀
RT @JAMAOnc: Rand ph 2 trial of men w recurrent hormone-sensitive, #oligometastatic #ProstateCancer w 1-3 mets, not on #hormonetherapy show…
RT @JAMAOnc: Rand ph 2 trial of men w recurrent hormone-sensitive, #oligometastatic #ProstateCancer w 1-3 mets, not on #hormonetherapy show…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @JAMAOnc: Rand ph 2 trial of men w recurrent hormone-sensitive, #oligometastatic #ProstateCancer w 1-3 mets, not on #hormonetherapy show…
RT @JAMAOnc: Rand ph 2 trial of men w recurrent hormone-sensitive, #oligometastatic #ProstateCancer w 1-3 mets, not on #hormonetherapy show…
RT @JAMAOnc: Rand ph 2 trial of men w recurrent hormone-sensitive, #oligometastatic #ProstateCancer w 1-3 mets, not on #hormonetherapy show…
RT @JAMAOnc: Rand ph 2 trial of men w recurrent hormone-sensitive, #oligometastatic #ProstateCancer w 1-3 mets, not on #hormonetherapy show…
RT @JAMAOnc: Rand ph 2 trial of men w recurrent hormone-sensitive, #oligometastatic #ProstateCancer w 1-3 mets, not on #hormonetherapy show…
RT @JAMAOnc: Rand ph 2 trial of men w recurrent hormone-sensitive, #oligometastatic #ProstateCancer w 1-3 mets, not on #hormonetherapy show…
Rand ph 2 trial of men w recurrent hormone-sensitive, #oligometastatic #ProstateCancer w 1-3 mets, not on #hormonetherapy shows significantly lower rate of dzs progr after stereotactic ablative radiotherapy (#SABR) vs observation https://t.co/X4al5EkuTW #G
RT @RadoncTables: ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT…
RT @RadoncTables: ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT…
RT @RadoncTables: ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT…
RT @RadoncTables: ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT…
RT @RadoncTables: ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT…
RT @RadoncTables: ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @RadoncTables: ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT…
RT @RadoncTables: ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT…
RT @RadoncTables: ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT…
ORIOLE: another incredible study for oligomets, this time in prostate ca, Phase II 1-3 oligomets were treated with SBRT vs obs SBRT improved PFS, new lesion progression, and T cell clonal proliferation Added to sheets: https://t.co/Ef2p5mQwJe Paper: h
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial https://t.co/kKdndjlcWW https://t.co/WzmyGzLc0w
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
Targeted molecular imaging meets #radonc ablation. Nice work!
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. JAMA Oncol #cancer #epidemiology https://t.co/ObN2bXVCKR
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
#Cancer | Radiacion intensa ayuda a disminuir la progresión en pacientes con #prostatecancer.
La #radioterapia ablativa estereotáctica es un enfoque de tratamiento prometedor para hombres con #CáncerDePróstata oligometastásico sensible a hormonas recurrente que desean retrasar el inicio de la terapia de privación de #andrógenos 👇
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @SoaresAndrey: Another nice trial looking at metastasis direct SBRT in oligometastatic castration sensitive prostate cancer. Interesting…
#oligomets #pscm #radonc @jryckman3
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @JAMAOnc: ORIOLE: compared to observation, stereotactic radiation delays progression in oligometastatic #prostatecancer and induces a sy…
RT @PBlanchardMD: ORIOLE out in @JAMAOnc: https://t.co/eLcrCMXcHY. Metastases directed #SBRT improves PFS over observation. Great work by…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…
#SBRT vs observation improves median PFS in oligorecurrent #prostatecancer #ORIOLE #phase2 @JAMAOnc https://t.co/IV3ETmReUZ
RT @jebibault: After @piet_ost’s STOMP trial, further confirmation that SBRT is relevant in oligometastatic #ProstateCancer! Progression of…
RT @ErinGillespieMD: 54 pts with oligomet prostate ca (1-3 lesions: 2/3 node-only, 1/3 bone-only). "Total consolidation of PSMA radiotracer…